|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | G01N 33/574 |
| (11) | Number of the document | 3408673 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17701686.2 |
| Date of filing the European patent application | 2017-01-24 | |
| (97) | Date of publication of the European application | 2018-12-05 |
| (45) | Date of publication and mention of the grant of the patent | 2020-07-08 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2017/051363 |
| Date | 2017-01-24 |
| (87) | Number | WO 2017/129537 |
| Date | 2017-08-03 |
| (30) | Number | Date | Country code |
| 16305065 | 2016-01-25 | EP |
| (72) |
CHIRON-BLONDEL, Marielle, FR
DREYMANN, Jennifer, FR
PACCARD, Caroline, FR
|
| (73) |
Sanofi,
54 Rue de la Boetie, 75008 Paris,
FR
|
| (54) | METHOD FOR PREDICTING THE OUTCOME OF A TREATMENT WITH AFLIBERCEPT OF A PATIENT SUSPECTED TO SUFFER FROM A CANCER BY MEASURING THE LEVEL OF A PLASMA BIOMARKER |
| METHOD FOR PREDICTING THE OUTCOME OF A TREATMENT WITH AFLIBERCEPT OF A PATIENT SUSPECTED TO SUFFER FROM A CANCER BY MEASURING THE LEVEL OF A PLASMA BIOMARKER |